Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
Flavia Lo Castro,1 Simona Guerzoni,1 Lanfranco Pellesi2 1Medical Toxicology, Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy; 2Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical...
Saved in:
Main Authors: | Lo Castro F, Guerzoni S, Pellesi L |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/052562f361c14f4fa8681714a9809356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
by: Alison M. Deighton, et al.
Published: (2021) -
Letter to the Editor: The Case for Publicly Funded Headache Surgery in Germany
by: Leonard Knoedler, et al.
Published: (2021) -
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
by: Stephanie J. Nahas, et al.
Published: (2021) -
The journal of headache and pain
Published: (2000) -
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
by: Timothy R. Smith, et al.
Published: (2021)